news Researchers discover class of drugs that could treat mantle cell lymphoma 23 June 2021 | By Victoria Rees (Drug Target Review) A screening campaign has revealed that small molecule inhibitors of the SOX 11 oncogene are toxic to mantle cell lymphoma in vitro.
news Inexpensive drug protects against COVID-19 inflammation in pre-clinical trials 31 March 2021 | By Victoria Rees (Drug Target Review) A drug called topotecan (TPT) was administered to mice up to four days after COVID-19 infection, reducing inflammation and morbidity.
news Two biomarkers of COVID-19 disease survival identified by researchers 25 August 2020 | By Victoria Rees (Drug Target Review) Scientists have revealed that the cytokines IL-6 and TNF-α are two biomarkers of inflammation that can predict the severity of COVID-19.